PCR arrays | GenomeWeb

PCR arrays

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.

In counting defective proviruses, approaches for estimating the size of HIV patients' virus reservoirs are throwing off estimates of treatment effectiveness.

LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.

Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.

NEW YORK (GenomeWeb News) – A study online today in the Journal of Clinical Investigation suggests cigarette smoke may exert some of its negative, cancer-promoting effects through an epigenetic pathway that curtails the activity of a microRNA called miR-487b.

Akonni Biosystems and Albany, NY-based Wadsworth Center are working together under a $300,000 National Institutes of Health grant to develop a closed amplicon PCR microarray to detect encephalitis- and meningitis-causing viruses in cerebral spinal fluid, Akonni said this week.

The companies have partnered to offer more than 100 pathway-focused gene expression panels validated for real-time PCR analysis on Fluidigm's BioMark system.

While Qiagen is primarily interested in SABiosciences' PCR Arrays and bioinformatics tools, the company also offers a number of microarray resources, including its own line of focused gene-expression arrays, a menu of reagent kits, data-analysis software, and core services on the Agilent Technologies and Illumina platforms.

Qiagen’s goal is to enable its customers to take an assay in a very early stage of discovery and validation and, “without transitioning platforms — to seamlessly move that into a companion diagnostic candidate if they so wish."

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.